Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Yasumasa, Higuchi, Makoto, Zhang, Bin, Huang, Shu-Ming, Iwata, Nobuhisa, Saido, Takaomi C., Maeda, Jun, Suhara, Tetsuya +2 more·2007·Neuron

Cited by (1,029)

Items 501–600 of 1,029

  1. Microglial priming and Alzheimer’s disease: a possible role for (early) immune challenges and epigenetics?
    Hoeijmakers, Lianne, Heinen, Yvonne, van Dam, Anne-Marie, Lucassen, Paul J., Korosi, Aniko · 2016 · Frontiers in Human Neuroscience
  2. Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy
    Malpetti, Maura, Passamonti, Luca, Rittman, Timothy, Jones, P. Simon, Vázquez Rodríguez, Patricia, Bevan‐Jones, W. Richard, Hong, Young T., Fryer, Tim D., Aigbirhio, Franklin I., O'Brien, John T. et al. · 2020 · Annals of Neurology
  3. Recent Advances in the Study of Bipolar/Rod-Shaped Microglia and their Roles in Neurodegeneration
    Ngan Pan Bennett Au, Chi Him Eddie Ma · 2017 · Frontiers in Aging Neuroscience
  4. Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation
    Amy H. Moore, Matthew J. Bigbee, Grace E. Boynton, Colin M. Wakeham, Hilary M. Rosenheim, Christopher J. Staral, James L. Morrissey, Amanda K. Hund · 2010 · Pharmaceuticals
  5. The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease
    Marco Magistri, Dmitry Velmeshev, Madina Makhmutova, Prutha Patel, Gregory C. Sartor, Claude‐Henry Volmar, Claes Wahlestedt, Mohammad Ali Faghihi · 2016 · Current Alzheimer Research
  6. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies
    Benjamin Combs, Chelsey Hamel, Nicholas M. Kanaan · 2016 · Neurobiology of Disease
  7. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer’s disease
    Saul, Anika, Sprenger, Frederik, Bayer, Thomas A., Wirths, Oliver · 2013 · Neurobiology of Aging
  8. Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations
    Yuto Uchida, Hirohito Kan, Keita Sakurai, Kenichi Oishi, Noriyuki Matsukawa · 2022 · Frontiers in Neuroscience
  9. Soluble pathogenic tau enters brain vascular endothelial cells and drives cellular senescence and brain microvascular dysfunction in a mouse model of tauopathy
    Stacy A. Hussong, Andy Q. Banh, Candice E. Van Skike, Angela O. Dorigatti, Stephen F. Hernandez, Matthew J. Hart, Beatriz Ferrán, Haneen Makhlouf, Maria E. Gaczynska, Paweł A. Osmulski et al. · 2023 · Nature Communications
  10. Alzheimer’s disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model
    Carling, Gillian K., Fan, Li, Foxe, Nessa R., Norman, Kendra, Wong, Man Ying, Zhu, Daphne, Corona, Carlo, Razzoli, Agnese, Yu, Fangmin, Yarahmady, Allan et al. · 2024 · Neuron
  11. The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction
    Maria Carmen Inda, Suhasini Joshi, Tai Wang, Alexander Bolaender, Srinivasa R. Gandu, John Koren, Alicia Yue, Tony Taldone, Pengrong Yan, Weilin Sun et al. · 2020 · Nature Communications
  12. Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses
    Meng, Jonathan X., Zhang, Yu, Saman, Dominik, Haider, Arshad M., De, Suman, Sang, Jason C., Brown, Karen, Jiang, Kun, Humphrey, Jane, Julian, Linda et al. · 2022 · Nature Communications
  13. Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
    Kendall B. E. Moore, Ta-Jung Hung, Jessica S. Fortin · 2023 · Drug Discovery Today
  14. Inflammasome assembly in neurodegenerative diseases
    Singh, Jagjit, Habean, Maria L., Panicker, Nikhil · 2023 · Trends in Neurosciences
  15. Neuroinflammation predicts disease progression in progressive supranuclear palsy
    Malpetti, Maura, Passamonti, Luca, Jones, Peter Simon, Street, Duncan, Rittman, Timothy, Fryer, Timothy D, Hong, Young T, Vàsquez Rodriguez, Patricia, Bevan-Jones, William Richard, Aigbirhio, Franklin I et al. · 2021 · Journal of Neurology, Neurosurgery & Psychiatry
  16. Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?
    Collins-Praino, Lyndsey E., Corrigan, Frances · 2017 · Brain, Behavior, and Immunity
  17. Tau monomer encodes strains
    Apurwa M Sharma, Talitha L. Thomas, DaNae R. Woodard, Omar M. Kashmer, Marc I. Diamond · 2018 · eLife
  18. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer’s Disease Transgenic Mice
    R. Kuwar, A. Rolfe, Long Di, Hallie Blevins, Yi-Ming Xu, Xuehan Sun, G. S. Bloom, Shi-Jun Zhang, Dong Sun · 2021 · Journal of Alzheimer's Disease
  19. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease
    Anke Van der Perren, Francesca Macchi, Jaan Toelen, Marianne Sylvia Carlon, Michael Maris, Henriëtte de Loor, Dirk R. J. Kuypers, Rik Gijsbers, Chris Van den Haute, Zeger Debyser et al. · 2015 · Neurobiology of Aging
  20. Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease
    Cho, Hanna, Choi, Jae Yong, Lee, Seung Ha, Lee, Jae Hoon, Choi, Young-Chul, Ryu, Young Hoon, Lee, Myoung Sik, Lyoo, Chul Hyoung · 2017 · Neurobiology of Aging
  21. Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer's disease brain
    Tagawa, Kazuhiko, Homma, Hidenori, Saito, Ayumu, Fujita, Kyota, Chen, Xigui, Imoto, Seiya, Oka, Tsutomu, Ito, Hikaru, Motoki, Kazumi, Yoshida, Chisato et al. · 2015 · Human Molecular Genetics
  22. Ca2+, Astrocyte Activation and Calcineurin/NFAT Signaling in Age-Related Neurodegenerative Diseases
    Pradoldej M Sompol, Christopher Mark Norris · 2018 · Frontiers in Aging Neuroscience
  23. Dysregulation of RNA Splicing in Tauopathies
    Daniel J. Apicco, Cheng Zhang, Brandon F. Maziuk, Lulu Jiang, Heather I. Ballance, Samantha Boudeau, Choong Yong Ung, Hu Li, Benjamin L. Wolozin · 2019 · Cell Reports
  24. Fyn Kinase Controls Tau Aggregation In Vivo
    Adam Briner, Jürgen Götz, Juan Carlos Polanco · 2020 · Cell Reports
  25. The Evolving Biology of Microglia in Alzheimer's Disease
    Malm, Tarja M., Jay, Taylor R., Landreth, Gary E. · 2015 · Neurotherapeutics
  26. Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology
    David J. Koss, Lianne Robinson, Benjamin D. Drever, Kaja Plucińska, Sandra Stoppelkamp, Peter Veselcic, Gernot Riedel, Bettina Platt · 2016 · Neurobiology of Disease
  27. The Dynamics and Turnover of Tau Aggregates in Cultured Cells
    Jing Guo, Arjan Buist, Alberto Carpinteiro Soares, Kathleen Callaerts, Sara Calafate, Frederik Stevenaert, Joshua P. Daniels, Bryan E. Zoll, Alex Crowe, Kurt R. Brunden et al. · 2016 · Journal of Biological Chemistry
  28. Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease
    Hanger, Diane P, Seereeram, Anjan, Noble, Wendy · 2009 · Expert Review of Neurotherapeutics
  29. The role of APOE in transgenic mouse models of AD
    Balu, Deebika, Karstens, Aimee James, Loukenas, Efstathia, Maldonado Weng, Juan, York, Jason M., Valencia-Olvera, Ana Carolina, LaDu, Mary Jo · 2019 · Neuroscience Letters
  30. Murine models of Alzheimer's disease and their use in developing immunotherapies
    Thomas Wısnıewskı, Einar M. Sigurdsson · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  31. Glial Cell–Mediated Deterioration and Repair of the Nervous System after Traumatic Brain Injury in a Rat Model as Assessed by Positron Emission Tomography
    Iwae Yu, Motoki Inaji, Jun Maeda, Takashi Okauchi, Tadashi Nariai, Kikuo Ohno, Makoto Higuchi, Tetsuya Suhara · 2010 · Journal of Neurotrauma
  32. Microglia and Synapse: Interactions in Health and Neurodegeneration
    Šišková, Zuzana, Tremblay, Marie-Ève · 2013 · Neural Plasticity
  33. Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor
    Jun Maeda, Takeharu Minamihisamatsu, Masafumi Shimojo, Xiaoyun Zhou, Maiko Ono, Yukio Matsuba, Bin Ji, Hideki Ishii, Masanao Ogawa, Hiroyasu Akatsu et al. · 2021 · Brain Communications
  34. Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons
    Teresa Rodríguez-Martín, Amy M. Pooler, Dawn H. W. Lau, Gábor M. Mórotz, Kurt J. De Vos, Jonathan Gilley, Michael P. Coleman, Diane P. Hanger · 2015 · Neurobiology of Disease
  35. Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development
    Adam L. Boxer, Michael Gold, Edward D. Huey, Fen‐Biao Gao, Edward A. Burton, Tiffany W. Chow, Aimee W. Kao, Blair R. Leavitt, Bruce T. Lamb, Megan E. Grether et al. · 2012 · Alzheimer s & Dementia
  36. In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease
    Tournier, Benjamin B., Tsartsalis, Stergios, Ceyzériat, Kelly, Garibotto, Valentina, Millet, Philippe · 2020 · Cells
  37. Examining the Relationship between Head Trauma and Neurodegenerative Disease: A Review of Epidemiology, Pathology and Neuroimaging Techniques
    Mark Sundman · 2014 · Journal of Alzheimer’s Disease & Parkinsonism
  38. Pathogenic tau accelerates aging-associated activation of transposable elements in the mouse central nervous system
    Ramirez, Paulino, Zuniga, Gabrielle, Sun, Wenyan, Beckmann, Adrian, Ochoa, Elizabeth, DeVos, Sarah L., Hyman, Bradley, Chiu, Gabriel, Roy, Ethan R., Cao, Wei et al. · 2022 · Progress in Neurobiology
  39. Dual role of nitric oxide in Alzheimer's disease
    Ali Azargoonjahromi · 2023 · Nitric Oxide
  40. Endoplasmic reticulum stress responses in mouse models of Alzheimer's disease: Overexpression paradigm versus knockin paradigm
    Shoko Hashimoto, Ayano Ishii, Naoko Kamano, Naoto Watamura, Takashi Saito, Toshio Ohshima, Makoto Yokosuka, Takaomi C. Saido · 2018 · Journal of Biological Chemistry
  41. Physical Exercise-Induced Myokines in Neurodegenerative Diseases
    Lee, Banseok, Shin, Myeongcheol, Park, Youngjae, Won, So-Yoon, Cho, Kyoung Sang · 2021 · International Journal of Molecular Sciences
  42. Introduction of Tau Oligomers into Cortical Neurons Alters Action Potential Dynamics and Disrupts Synaptic Transmission and Plasticity
    Emily Hill, Thomas K. Karikari, Kevin G. Moffat, Magnus J. E. Richardson, Mark John Wall · 2019 · eNeuro
  43. Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease
    Yunying Yang, Zhentao Zhang · 2020 · Frontiers in Aging Neuroscience
  44. Tau: A Signaling Hub Protein
    Rebecca L. Mueller, Benjamin Combs, Mohammed M. Alhadidy, Scott T. Brady, Gerardo A. Morfini, Nicholas M. Kanaan · 2021 · Frontiers in Molecular Neuroscience
  45. An experimental rat model of sporadic Alzheimer’s disease and rescue of cognitive impairment with a neurotrophic peptide
    Silvia Bolognin, Julie Blanchard, Xiaochuan Wang, Gustavo Basurto‐Islas, Yunn Chyn Tung, Erik Kohlbrenner, Inge Grundke, Khalid Iqbal · 2011 · Acta Neuropathologica
  46. Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice
    Magali Dumont, Cliona Stack, Ceyhan Elipenahli, Shari Jainuddin, Meri Gerges, Natalia N. Starkova, Noel Ylagan Calingasan, Lichuan Yang, Davide Tampellini, Anatoly A. Starkov et al. · 2012 · Human Molecular Genetics
  47. Pharmacological Rescue of Long-Term Potentiation in Alzheimer Diseased Synapses
    G. Aleph Prieto, Brian H. Trieu, Cindy T. Dang, Tina V. Bilousova, Karen H. Gylys, Nicole C. Berchtold, GARY S. LYNCH, Carl W. Cotman · 2016 · Journal of Neuroscience
  48. Treadmill Running Reverses Cognitive Declines due to Alzheimer Disease
    Jinkyung Cho, Min‐Kyoo Shin, Donghyun Kim, Inhwan Lee, Shinuk Kim, Hyun‐Sik Kang · 2015 · Medicine & Science in Sports & Exercise
  49. Elucidating the interactive roles of glia in Alzheimer’s disease using established and newly developed experimental models
    Chun, Heejung, Marriott, Ian, Lee, C. Justin, Cho, Hansang · 2018 · Frontiers in Neurology
  50. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model
    Masafumi Shimojo, Hiroyuki Takuwa, Yuhei Takado, Masaki Tokunaga, Satoshi Tsukamoto, Keiichiro Minatohara, Maiko Ono, Chie Seki, Jun Maeda, Takuya Urushihata et al. · 2020 · Journal of Neuroscience
  51. Lowering Synaptogyrin-3 expression rescues Tau-induced memory defects and synaptic loss in the presence of microglial activation
    Pablo Largo‐Barrientos, Nuno Apóstolo, Eline Creemers, Zsuzsanna Callaerts‐Vegh, Jef Swerts, Caitlin Davies, Joseph McInnes, Keimpe D. B. Wierda, Bart De Strooper, Tara L. Spires‐Jones et al. · 2021 · Neuron
  52. Human Alzheimer’s disease reactive astrocytes exhibit a loss of homeostastic gene expression
    Dai, David L., Li, Mingyao, Lee, Edward B. · 2023 · Acta Neuropathologica Communications
  53. Analysis of in vivo turnover of tau in a mouse model of tauopathy
    Kaoru Yamada, Tirth K. Patel, Katja Hochgräfe, Thomas E. Mahan, Hong Jiang, Floy R. Stewart, Eva‐Maria Mandelkow, David M. Holtzman · 2015 · Molecular Neurodegeneration
  54. Blast exposure causes dynamic microglial/macrophage responses and microdomains of brain microvessel dysfunction
    Bertrand R. Huber, James S. Meabon, Zachary S. Hoffer, Jing Zhang, Jake G. Hoekstra, Kathleen Farrell Pagulayan, Paul J. McMillan, Cynthia L. Mayer, William A. Banks, Brian C. Kraemer et al. · 2016 · Neuroscience
  55. Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
    Wirths, Oliver, Zampar, Silvia · 2020 · International Journal of Molecular Sciences
  56. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model
    Lynn van Olst, Daan Verhaege, Marc Franssen, Alwin Kamermans, Bart Roucourt, Sofie Carmans, Ellen Ytebrouck, Susanne M. A. van der Pol, Dennis D. Wever, Marko A. Popovic et al. · 2020 · Neurobiology of Aging
  57. A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic Mice
    Takako Niikura, Elkhansa Sidahmed, Chiho Hirata‐Fukae, Paul S. S Aisen, Yasuji Matsuoka · 2011 · PLoS ONE
  58. Microglial activation in brain lesions with tau deposits: Comparison of human tauopathies and tau transgenic mice TgTauP301L
    Atsushi Sasaki, Takeshi Kawarabayashi, Tetsuro Murakami, Etsuro Matsubara, Masaki Ikeda, Haruo Hagiwara, David A. Westaway, Peter St George‐Hyslop, Mikio Shoji, Yoichi Nakazato · 2008 · Brain Research
  59. p53 prevents neurodegeneration by regulating synaptic genes
    Paola Merlo, Bess E Frost, Shouyong Peng, Yawei J. Yang, Peter J. Park, Mel Β. Feany · 2014 · Proceedings of the National Academy of Sciences
  60. The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes
    Cristian A. Lasagna‐Reeves, Urmi Sengupta, Diana Laura Castillo‐Carranza, Julia E. Gerson, Marcos Jair Guerrero‐Munoz, Juan Carlos Troncoso, George R. Jackson, Rakez Kayed · 2014 · Acta Neuropathologica Communications
  61. TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits
    Hongjie Wang, Ruizhi Wang, Iván Carrera, Shaohua Xu, Madepalli Krishnappa Lakshmana · 2016 · eNeuro
  62. AMPA Receptor Trafficking in Natural and Pathological Aging
    Sandra Jurado · 2018 · Frontiers in Molecular Neuroscience
  63. In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: A PET and MRI study
    Miyoshi, Michie, Shinotoh, Hitoshi, Wszolek, Zbigniew K., Strongosky, Audrey J., Shimada, Hitoshi, Arakawa, Ryosuke, Higuchi, Makoto, Ikoma, Yoko, Yasuno, Fumihiko, Fukushi, Kiyoshi et al. · 2010 · Parkinsonism & Related Disorders
  64. Misfolded Truncated Protein τ Induces Innate Immune Response via MAPK Pathway
    Kovac, Andrej, Zilka, Norbert, Kazmerova, Zuzana, Cente, Martin, Zilkova, Monika, Novak, Michal · 2011 · The Journal of Immunology
  65. Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD
    Hongbo Chen, Mark W. Kankel, Susan C. Su, Steve Han, Dimitry Ofengeim · 2018 · Cell Death and Differentiation
  66. Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action
    Katriona L. Hole, Robert J. Williams · 2020 · Brain Plasticity
  67. Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
    Chu Chen · 2023 · Pharmacology & Therapeutics
  68. In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy
    Crescenzi, Rachelle, DeBrosse, Catherine, Nanga, Ravi Prakash Reddy, Reddy, Sanjana, Haris, Mohammed, Hariharan, Hari, Iba, Michiyo, Lee, Virginia M.Y., Detre, John A., Borthakur, Arijitt et al. · 2014 · NeuroImage
  69. Neuroinflammatory Gene Regulation, Mitochondrial Function, Oxidative Stress, and Brain Lipid Modifications With Disease Progression in Tau P301S Transgenic Mice as a Model of Frontotemporal Lobar Degeneration-Tau
    Irene López‐González, Ester Aso, Margarita Carmona, Mercedes Armand‐Ugón, Rosi Blanco, Alba Naudí, Rosanna Cabré, Manuel Portero‐Otín, Reinald Pamplona, Isidró Ferrer · 2015 · Journal of Neuropathology & Experimental Neurology
  70. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease
    Nataša Z. Kuštrimović, Franca Marino, Marco Cosentino · 2018 · Current Medicinal Chemistry
  71. The Spleen Tyrosine Kinase (Syk) Regulates Alzheimer Amyloid-β Production and Tau Hyperphosphorylation
    Paris, Daniel, Ait-Ghezala, Ghania, Bachmeier, Corbin, Laco, Gary, Beaulieu-Abdelahad, David, Lin, Yong, Jin, Chao, Crawford, Fiona, Mullan, Michael · 2014 · Journal of Biological Chemistry
  72. Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
    Weston, Lea L., Jiang, Shanya, Chisholm, Devon, Jantzie, Lauren L., Bhaskar, Kiran · 2021 · Journal of Neuroinflammation
  73. Insulin resistance, neuroinflammation, and Alzheimer’s disease
    Dema Najem, Michelle Bamji‐Mirza, Nina Chang, Qing Yan Liu, Wandong Zhang · 2014 · Reviews in the Neurosciences
  74. Passive immunotherapy of tauopathy targeting pSer413‐tau: a pilot study in mice
    Tomohiro Umeda, Hiroshi Eguchi, Yuichi Kunori, Yoichi Matsumoto, Taizo Taniguchi, Hiroshi Mori, Takami Tomiyama · 2015 · Annals of Clinical and Translational Neurology
  75. Therapeutic potential of nuclear receptor agonists in Alzheimer's disease
    Miguel Moutinho, Gary E. Landreth · 2017 · Journal of Lipid Research
  76. CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease
    Jeremy L. Koppel, Valérie Vingtdeux, Philippe Marambaud, Cristina d’Abramo, Heidy T. Jimenez, Mark Stauber, Rachel Friedman, Peter Davies · 2013 · Molecular Medicine
  77. Stem Cells of the Aging Brain
    A. Nicaise, Cory M. Willis, S. Crocker, S. Pluchino · 2020 · Frontiers in Aging Neuroscience
  78. Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model
    Carolyn N. Mann, Shamulailatpam Shreedarshanee Devi, Corey T. Kersting, Amber V. Bleem, Celeste M M. Karch, David M. Holtzman, Gilbert Gallardo · 2022 · Science Translational Medicine
  79. P-tau217 correlates with neurodegeneration in Alzheimer’s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy
    Denghong Zhang, Wei Zhang, Ming Chen, Xuheng Gao, Huilong Yuan, Xiaojie Lin, Xinru Mao, Chunping Wang, Xiaoyi Guo, Ying Du et al. · 2024 · Neuron
  80. Organotypic Brain Slice Cultures of Adult Transgenic P301S Mice—A Model for Tauopathy Studies
    Agneta Mewes, Heike Franke, David L. Singer · 2012 · PLoS ONE
  81. WNT5A Signaling Contributes to Aβ-Induced Neuroinflammation and Neurotoxicity
    Bei Li, Ling Zhong, Xiangling Yang, T. Andersson, Min Huang, Shao-Jun Tang · 2011 · PLoS ONE
  82. Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species
    Julia E. Gerson, Diana Laura Castillo‐Carranza, Rakez Kayed · 2014 · ACS Chemical Neuroscience
  83. Nuclear Magnetic Resonance Analysis of the Acetylation Pattern of the Neuronal Tau Protein
    Amina Kamah, Isabelle Huvent, François‐Xavier Cantrelle, Haoling Qi, Guy M. Lippens, Isabelle Landrieu, Caroline Smet‐Nocca · 2014 · Biochemistry
  84. The <scp>NLRP3</scp> inflammasome modulates tau pathology and neurodegeneration in a tauopathy model
    Stancu, Ilie Cosmin, Lodder, Chritica, Botella Lucena, Pablo, Vanherle, Sarah, Gutiérrez de Ravé, Manuel, Terwel, Dick, Bottelbergs, Astrid, Dewachter, Ilse · 2022 · Glia
  85. Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
    Ni, Ruiqing, Ji, Bin, Ono, Maiko, Sahara, Naruhiko, Zhang, Ming-Rong, Aoki, Ichio, Nordberg, Agneta, Suhara, Tetsuya, Higuchi, Makoto · 2018 · Journal of Nuclear Medicine
  86. Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How
    Lewandowski, Cutler T., Maldonado Weng, Juan, LaDu, Mary Jo · 2020 · Neurobiology of Disease
  87. Astrocyte senescence and SASP in neurodegeneration: tau joins the loop
    Kyra Ungerleider, Jessica A. Beck, Delphine Lissa, Casmir Turnquist, Izumi Horikawa, Brent T. Harris, Curtis C. Harris · 2021 · Cell Cycle
  88. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia
    Chritica Lodder, Isabelle Scheyltjens, Ilie‐Cosmin Stancu, Pablo Botella Lucena, Manuel Gutiérrez de Ravé, Sarah Vanherle, Tim Vanmierlo, Niels Cremers, Hannah Vanrusselt, Bert Brône et al. · 2021 · Acta Neuropathologica Communications
  89. Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART
    Alexander J. Ehrenberg, Michael A. Kelberman, Kathy Y Liu, Martin J. Dahl, David Weinshenker, Neus Falgàs, Shubir Dutt, Mara Mather, Mareike Ludwig, Matthew J. Betts et al. · 2023 · Alzheimer s & Dementia
  90. Membrane trafficking in neuronal maintenance and degeneration
    Dong Wang, Chih‐Chiang Chan, Smita Cherry, P. Robin Hiesinger · 2012 · Cellular and Molecular Life Sciences
  91. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss
    Tara E. Tracy, Li Gan · 2017 · BioEssays
  92. Attenuation of microglial activation in a mouse model of Alzheimer’s disease via NFAT inhibition
    Lalida Rojanathammanee, Angela Marie Floden, Gunjan Dhawan Manocha, Colin Kelly Combs · 2015 · Journal of Neuroinflammation
  93. Chronic Intermittent Hypoxia Enhances Pathological Tau Seeding, Propagation, and Accumulation and Exacerbates Alzheimer-like Memory and Synaptic Plasticity Deficits and Molecular Signatures
    Syed Faraz Kazim, Abhijeet Sharma, Sivaprakasam R. Saroja, Joon Ho Seo, Chloe S. Larson, Aarthi Ramakrishnan, Minghui Wang, Robert D. Blitzer, Li Shen, Catherine J. Peña et al. · 2021 · Biological Psychiatry
  94. Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF
    Hitt, Brian D., Vaquer-Alicea, Jaime, Manon, Victor A., Beaver, Joshua D., Kashmer, Omar M., Garcia, Jan N., Diamond, Marc I. · 2021 · Acta Neuropathologica Communications
  95. Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy
    Johanna L. Crimins, Anne B. Rocher, Alan Peters, Penny L. Shultz, Jada M. Lewis, Jennifer Irene Luebke · 2011 · Acta Neuropathologica
  96. Chronic stimulation of alpha-2A-adrenoceptors with guanfacine protects rodent prefrontal cortex dendritic spines and cognition from the effects of chronic stress
    Hains, Avis Brennan, Yabe, Yoko, Arnsten, Amy F.T. · 2015 · Neurobiology of Stress
  97. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy
    Si Jie Tang, Arman Fesharaki‐Zadeh, Hideyuki Takahashi, Sarah Helena Nies, Levi M. Smith, Anin Luo, Annabel S. Chyung, Marius Chiasseu, Stephen M. Strittmatter · 2020 · Acta Neuropathologica Communications
  98. The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
    Sriram Balusu, Bart De Strooper · 2024 · Acta Neuropathologica
  99. Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy
    M. Hebron, I. Lonskaya, Paul Olopade, S. Selby, F. Pagán, C. Moussa · 2014 · Journal of Clinical & Cellular Immunology
  100. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease
    Clarissa Ferolla Mendonça, Magdalena Kuras, Fábio César Sousa Nogueira, Indira Plá, Tibor Hortobágyi, László Csiba, Miklós Palkovits, Éva Renner, Péter Döme, György Marko‐Varga et al. · 2019 · Neurobiology of Disease